Anti-cytosolic 5′-nucleotidase 1A (NT5C1A) autoantibodies, which are prevalent in adult patients with inclusion body myositis, were detected in 27% of a JIIM cohort, although not specifically, and associated with severe disease [76]. This evidence concerns the gene NT5C1A and inclusion body myositis.